Beam Therapeutics Inc.
Organization details
- Legal name
- Beam Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BEAM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001745999
Board of directors
-
Carole Ho · DirectorSince 2023
-
Chirfi Guindo · DirectorSince 2024
-
Christi Shaw · DirectorSince 2023
-
Graham K. Cooper · DirectorSince 2023
-
John M. Evans · Director · CEOSince 2023
- Since 2023
-
Kathleen E. Walsh · DirectorSince 2023
- Since 2023
-
Mark Fishman · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.4%
-
90.5%
-
98.8%
Board connections
4 of this board's directors also sit on 15 other boards. 14 are in the same sector.
-
Agios Pharmaceuticals Inc. Same sectorvia John Maraganore
- via Christi Shaw
-
Boundless Bio Inc. Same sectorvia Kristina Burow
-
City Therapeutics Inc. Same sectorvia John Maraganore
-
Gossamer Bio Inc. Same sectorvia Kristina Burow
-
Hemab Therapeutics Holdings Inc. Same sectorvia John Maraganore
-
Kardigan Inc. Same sectorvia Kristina Burow
-
Kymera Therapeutics Inc. Same sectorvia John Maraganore
-
Kyverna Therapeutics Inc. Same sectorvia Christi Shaw
-
Neumora Therapeutics Inc. Same sectorvia Kristina Burow
-
ProKidney Corp. Same sectorvia John Maraganore
-
Rapport Therapeutics Inc. Same sectorvia John Maraganore
-
Royalty Pharma plc Same sectorvia Carole Ho
-
Scholar Rock Holding Corporation Same sectorvia Kristina Burow
-
Takeda Pharmaceutical Company Limited Same sectorvia John Maraganore
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,736,002
- 31 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16, 2026 | John M. Evans Director, Officer (CEO) | Option exercise | +25,000 | $1.03 | $25,750 |
| Oct 16, 2026 | John M. Evans Director, Officer (CEO) | Open-market sale | −25,000 | $23.98 | $599,595 |
| Oct 15, 2026 | John M. Evans Director, Officer (CEO) | Option exercise | +25,000 | $1.03 | $25,750 |
| Oct 15, 2026 | John M. Evans Director, Officer (CEO) | Open-market sale | −25,000 | $23.57 | $589,150 |
| Oct 1, 2026 | Cavanagh Bethany J Officer (SVP, Finance and Treasurer) | Open-market sale | −187 | $24.41 | $4,565 |
| Sep 24, 2026 | Ciaramella Giuseppe Officer (President) | Gift | −123,407 | — | — |
| Jul 27, 2026 | Simon Amy Officer (Chief Medical Officer) | Open-market sale | −16,667 | $25.74 | $429,009 |
| Jun 30, 2026 | Simon Amy Officer (Chief Medical Officer) | Open-market sale | −373 | $34.73 | $12,954 |
| Jun 30, 2026 | John M. Evans Director, Officer (CEO) | Option exercise | +25,000 | $1.03 | $25,750 |
| Jun 30, 2026 | John M. Evans Director, Officer (CEO) | Open-market sale | −23,100 | $34.26 | $791,406 |
| Jun 30, 2026 | John M. Evans Director, Officer (CEO) | Open-market sale | −1,900 | $34.84 | $66,196 |
| Jun 29, 2026 | John M. Evans Director, Officer (CEO) | Option exercise | +18,663 | $0.67 | $12,504 |
| Jun 29, 2026 | John M. Evans Director, Officer (CEO) | Option exercise | +6,337 | $1.03 | $6,527 |
| Jun 29, 2026 | John M. Evans Director, Officer (CEO) | Open-market sale | −13,421 | $35.13 | $471,480 |
| Jun 29, 2026 | John M. Evans Director, Officer (CEO) | Open-market sale | −11,579 | $35.91 | $415,802 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Beam Therapeutics Inc.
Who is the CEO of Beam Therapeutics Inc.?
John M. Evans is Beam Therapeutics Inc.'s CEO.
How many directors are on Beam Therapeutics Inc.'s board?
Beam Therapeutics Inc.'s board has 9 directors: Carole Ho, Chirfi Guindo, Christi Shaw, Graham K. Cooper, John M. Evans, John Maraganore, Kathleen E. Walsh, Kristina Burow and Mark Fishman.
Are Beam Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Beam Therapeutics Inc. insiders made no open-market purchases and sold $19.7 million of shares in 31 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="beam-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.